New fertility drug aims to boost IVF live birth rates
Disease control
Recruiting now
This phase 3 trial tests whether a daily injection of human menopausal gonadotropin (hMG) can help women with infertility develop more eggs and achieve a live birth during IVF. About 659 women aged 18-42 will receive either the hormone or a placebo. The main goal is to see if the…
Phase: PHASE3 • Sponsor: Granata Bio Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC